
What We Do
The HudsonAlpha Clinical Services Lab, LLC (CSL) provides testing for those who embark on a personal journey through genomics. The CSL is wholly owned by the HudsonAlpha Institute for Biotechnology, a non-profit research institute committed to advancing genomic knowledge by bringing scientific discoveries into clinical care. The CSL team works to solve undiagnosed diseases and end diagnostic odysseys. Our goal is to provide support that goes beyond the genome, helping resolve uncertainty and seeking answers for symptoms that remain unexplained by DNA sequencing.
Have questions?
Our team is available to answer your questions and work with you to create a customized plan that is right for you.
CLIA Certification | CAP Accreditation
The HudsonAlpha Clinical Services Lab (CSL) offers a sequencing and interpretation pipeline that is accredited by the College of American Pathologists (CAP) and certified through Clinical Laboratory Improvement Amendments (CLIA).
The CSL does not yet accept samples from New York.
Consistent with Laboratory Developed Tests, CSL’s personalized genomic testing has not been cleared or approved by the U.S. Food and Drug Administration.
CLIA ID #: 01D2086581 | CAP #: 8051488
Clinical Services Lab Team
Our team consists of internationally-revered clinicians, researchers, analysts and informaticians.

Ghunwa Nakouzi, PhD, FACMG
Clinical Lab Director

Henry Tsai, PhD
Clinical Assistant Lab Director

Brett Sundlof, BS
Clinical Supervisor

Melissa Kelly, PhD
Clinical Genomic Variant Scientist

Nadiya Sosonkina, PhD
Clinical Translational Scientist

Kelly Williams, PhD
Clinical Translational Scientist

Meghan Letson
Laboratory Technician

Laura Griffin
Clinical Lab Technologist

John Mote
Clinical Laboratory Scientist
Executive Board
Executive Board of the HudsonAlpha Clinical Services Lab
Barbara Fisk

Jim Hudson

Officers
Officers of the HudsonAlpha Clinical Services Lab
Richard M. Myers

Chief Executive Officer
Pete Yanul

Chief Financial Officer
Danny Windham
